NCI Clinical and Translational Exploratory/ Developmental Studies (R21)

This grant supports preclinical and early phase clinical research, as well as correlative studies, directly related to advancements in cancer treatment, diagnosis, prevention, comparative oncology, symptom management, or reduction of cancer disparities.

This Call does not support research that focuses on basic cancer biology nor does it fund later- stage clinical trials. 

Funding: $275,000 total 

Duration: 2 years 

Research Authority due dates: 10 days prior to submission 

LOI (encouraged) due dates:  10.9.22, 13.1.23, 12.5.23, 10.9.23, 13.1.24, 12.5.24, 10.9.24, 13.1.25, 12.5.25

Full proposal due dates: 10.10.22, 13.2.23, 12.6.23, 10.10.23, 13.2.24, 12.6.24, 10.10.24, 13.2.25, 12.6.25